<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Charles River Laboratories — News on 6ix</title>
    <link>https://6ix.com/company/charles-river-laboratories</link>
    <description>Latest news and press releases for Charles River Laboratories on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 12:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/charles-river-laboratories" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835595e78dffbe2df0eb021.webp</url>
      <title>Charles River Laboratories</title>
      <link>https://6ix.com/company/charles-river-laboratories</link>
    </image>
    <item>
      <title>Charles River Highlights Effectiveness of VCGs in Toxicology</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-highlights-effectiveness-of-vcgs-in-toxicology</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-highlights-effectiveness-of-vcgs-in-toxicology</guid>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., April 21, 2026--Charles River Laboratories International, Inc. (NYSE: CRL) has shared the results of a retrospective analysis in Regulatory Toxicology and Pharmacology, showing that virtual control groups (VCGs) can preserve scientific integrity while reducing reliance on animal models. The review, which looked at 20 toxicology studies that replaced concurrent control groups (CCGs) with curated VCGs, and compared the outcomes across study-level decisions and detailed endpoints</description>
    </item>
    <item>
      <title>Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-schedules-first-quarter-2026-earnings-release-and-conference-call</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-schedules-first-quarter-2026-earnings-release-and-conference-call</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., April 16, 2026--Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call</description>
    </item>
    <item>
      <title>Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-advances-cardiovascular-health-awareness-through-support-of-the-american-heart-association</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-advances-cardiovascular-health-awareness-through-support-of-the-american-heart-association</guid>
      <pubDate>Thu, 09 Apr 2026 20:30:00 GMT</pubDate>
      <description>WILMINGTON, Mass., April 09, 2026--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health, to support cardiovascular disease awareness, prevention, and community health initiatives.</description>
    </item>
    <item>
      <title>NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/nsg-bio-and-charles-river-sign-memorandum-of-understanding-to-strengthen-support-for-biotech-innovation-in-singapore</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/nsg-bio-and-charles-river-sign-memorandum-of-understanding-to-strengthen-support-for-biotech-innovation-in-singapore</guid>
      <pubDate>Thu, 09 Apr 2026 02:00:00 GMT</pubDate>
      <description>NSG Bio announced the signing of a Memorandum of Understanding (MOU) with Charles River Laboratories (&quot;Charles River&quot;), marking a new collaboration aimed at strengthening support for biotech companies building and scaling in Singapore. The MOU was signed during Charles River&apos;s APAC Biomanufacturing Leadership Summit 2026, reflecting a shared commitment to accelerating innovation through stronger connections across the life sciences value chain.</description>
    </item>
    <item>
      <title>Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/locus-cell-taiwan-based-cell-and-gene-therapy-cdmo-signs-mou-with-charles-river-at-apac-biomanufacturing-leadership-summit</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/locus-cell-taiwan-based-cell-and-gene-therapy-cdmo-signs-mou-with-charles-river-at-apac-biomanufacturing-leadership-summit</guid>
      <pubDate>Wed, 11 Mar 2026 23:46:00 GMT</pubDate>
      <description>Locus Cell Co., Ltd. (&quot;Locus Cell&quot;), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River Laboratories (&quot;Charles River&quot;), a global contract research organization (CRO) providing drug development support and biologics testing solutions, have signed a Memorandum of Understanding (MoU) during the APAC Biomanufacturing Leadership Summit 2026 in Singapore.</description>
    </item>
    <item>
      <title>Charles River Laboratories to Present at TD Cowen and Barclays Conferences</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-to-present-at-td-cowen-and-barclays-conferences</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-to-present-at-td-cowen-and-barclays-conferences</guid>
      <pubDate>Mon, 02 Mar 2026 13:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., March 02, 2026--Charles River Laboratories to Present at TD Cowen and Barclays Conferences</description>
    </item>
    <item>
      <title>IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/iqvia-signs-agreement-to-acquire-drug-discovery-assets-from-charles-river-laboratories-expanding-end-to-end-drug-discovery-capabilities</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/iqvia-signs-agreement-to-acquire-drug-discovery-assets-from-charles-river-laboratories-expanding-end-to-end-drug-discovery-capabilities</guid>
      <pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
      <description>RESEARCH TRIANGLE PARK, N.C., February 25, 2026--IQVIA Holdings Inc. (&quot;IQVIA&quot;) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.</description>
    </item>
    <item>
      <title>Charles River Laboratories Provides Update on Planned Divestitures</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-provides-update-on-planned-divestitures</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-provides-update-on-planned-divestitures</guid>
      <pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., February 25, 2026--Charles River Laboratories Provides Update on Planned Divestitures</description>
    </item>
    <item>
      <title>Charles River Laboratories Announces Executive Appointments</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-announces-executive-120100763</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-announces-executive-120100763</guid>
      <pubDate>Wed, 18 Feb 2026 12:01:00 GMT</pubDate>
      <description>WILMINGTON, Mass., February 18, 2026--Charles River Laboratories Announces Executive Appointments</description>
    </item>
    <item>
      <title>Mariner Pairs with State Street to Scale Operations and Support Growth to 5,000 Advisors via Charles River’s Wealth Platform</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/mariner-pairs-with-state-street-to-scale-operations-and-support-growth-to-5000-advisors-via-charles-rivers-wealth-platform</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/mariner-pairs-with-state-street-to-scale-operations-and-support-growth-to-5000-advisors-via-charles-rivers-wealth-platform</guid>
      <pubDate>Thu, 12 Feb 2026 13:30:00 GMT</pubDate>
      <description>BOSTON, February 12, 2026--State Street Corporation (NYSE: STT) today announced that Mariner, a privately held national financial services firm, will implement Charles River’s Wealth Management Solution to streamline its operations and support its long-term growth strategy, including its goal of expanding to 5,000 advisors.</description>
    </item>
    <item>
      <title>Charles River Wealth to Expand Capabilities Supporting Private Assets within Unified Managed Accounts (UMA)</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-wealth-to-expand-capabilities-supporting-private-assets-within-unified-managed-accounts-uma</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-wealth-to-expand-capabilities-supporting-private-assets-within-unified-managed-accounts-uma</guid>
      <pubDate>Thu, 22 Jan 2026 16:00:00 GMT</pubDate>
      <description>BOSTON, January 22, 2026--Charles River Development, a State Street company, today announced plans to expand its support of private market assets within the unified managed accounts (UMA) capabilities offered through the Charles River Investment Management Solution (IMS). Through new enhancements to Charles River IMS, the offering aims to provide a streamlined and integrated solution with advanced portfolio management capabilities across public and private assets within a single portfolio. The e</description>
    </item>
    <item>
      <title>Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-schedules-fourth-213000491</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-schedules-fourth-213000491</guid>
      <pubDate>Wed, 21 Jan 2026 21:30:00 GMT</pubDate>
      <description>WILMINGTON, Mass., January 21, 2026--Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call</description>
    </item>
    <item>
      <title>Charles River Enters Manufacturing Collaboration with Gazi University</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-enters-manufacturing-collaboration-with-gazi-university</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-enters-manufacturing-collaboration-with-gazi-university</guid>
      <pubDate>Wed, 21 Jan 2026 13:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., January 21, 2026--Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy studies.</description>
    </item>
    <item>
      <title>Charles River Laboratories Provides Business Updates</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-provides-business-213000230</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-provides-business-213000230</guid>
      <pubDate>Mon, 12 Jan 2026 21:30:00 GMT</pubDate>
      <description>WILMINGTON, Mass., January 12, 2026--Charles River Laboratories Provides Business Updates</description>
    </item>
    <item>
      <title>Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-announces-planned-retirement-of-james-c-foster-and-ceo-succession-plan</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-announces-planned-retirement-of-james-c-foster-and-ceo-succession-plan</guid>
      <pubDate>Thu, 08 Jan 2026 13:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., January 08, 2026--Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan</description>
    </item>
    <item>
      <title>Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-extends-commitment-to-advanced-therapy-developers-with-second-incubator-program-cohort</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-extends-commitment-to-advanced-therapy-developers-with-second-incubator-program-cohort</guid>
      <pubDate>Thu, 11 Dec 2025 13:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., December 11, 2025--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell &amp; Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort announced in April 2025, the program provides early-stage biotechnology pioneers with access to extensive scientific and commercial expertise, as well as a comprehensive ecosystem of discovery, development, and manufacturing capabilities, to expedite the developme</description>
    </item>
    <item>
      <title>Akadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance Program</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/akadeum-life-sciences-announces-establishment-of-the-akadeum-cdmo-alliance-program</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/akadeum-life-sciences-announces-establishment-of-the-akadeum-cdmo-alliance-program</guid>
      <pubDate>Tue, 09 Dec 2025 14:16:00 GMT</pubDate>
      <description>Akadeum Life Sciences, the leader in buoyant cell separation, announces the establishment of the Akadeum CDMO Alliance™ and the first two members in the consortium. The exclusive Akadeum CDMO Alliance builds on the strong relationships Akadeum has built with leading CDMOs in the cell therapy space and seeks to be a bastion for innovation in reducing costs, time, and access to cell therapies while delivering best-in-class performance.</description>
    </item>
    <item>
      <title>T. Rowe Price Transitions to Charles River’s Enterprise Multi-Asset Investment Management Platform</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/t-rowe-price-transitions-to-charles-rivers-enterprise-multi-asset-investment-management-platform</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/t-rowe-price-transitions-to-charles-rivers-enterprise-multi-asset-investment-management-platform</guid>
      <pubDate>Thu, 04 Dec 2025 13:30:00 GMT</pubDate>
      <description>BOSTON, December 04, 2025--Charles River Development, a State Street Company, announced today the expansion of its relationship with T. Rowe Price through the migration to the SaaS-deployed Charles River Investment Management Solution (Charles River IMS).</description>
    </item>
    <item>
      <title>Charles River Laboratories to Present at Evercore Healthcare Conference</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-to-present-at-evercore-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-to-present-at-evercore-healthcare-conference</guid>
      <pubDate>Mon, 01 Dec 2025 13:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., December 01, 2025--Charles River Laboratories to Present at Evercore Healthcare Conference</description>
    </item>
    <item>
      <title>Charles River Laboratories to Present at Jefferies Global Healthcare Conference</title>
      <link>https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-to-present-at-jefferies-global-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/charles-river-laboratories/news/charles-river-laboratories-to-present-at-jefferies-global-healthcare-conference</guid>
      <pubDate>Mon, 17 Nov 2025 13:00:00 GMT</pubDate>
      <description>WILMINGTON, Mass., November 17, 2025--Charles River Laboratories to Present at Jefferies Global Healthcare Conference</description>
    </item>
  </channel>
</rss>